Carnosinenone

Other Combinations

Brand: Cardiovascular Research

CapsuleOther CombinationsOn Market
Click to view full label

Net Contents

60 Capsule(s)

Serving Size

1–2 Capsule(s)

Servings Per Container

60

Supplement Form

Capsule

Bar Code (UPC/SKU)

Not specified

Product Version

Not Present

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

2Active Ingredients

2 distinct active ingredients are disclosed in Supplement Facts.

100%Amount Transparency

Every active ingredient discloses a specific amount per serving.

1% Daily Value Coverage

1 ingredients report a %DV; 1 meet or exceed 100% DV.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1–2 Capsule(s) · 1 per day

IngredientAmount Per Serving% Daily Value
Vitamin E30 IU100%
L-Carnosine50 mg

Percent Daily Values are based on a 2000 calorie diet

Other Ingredients

Magnesium StearateSilicon Dioxide

Target Groups

Adult (18 - 50 Years)

Label Claims

All Other

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

DIRECTIONS Take one or two capsules daily or as directed by a physician.

Formulation

Formulation re: Does NOT Contain

This product is free of corn, soy, yeast, wheat and other common allergens.

FDA Statements

FDA Statement of Identity

A NUTRITIONAL SUPPLEMENT

Other Label Statements

General Statements: All Other Content

CARNOSINE is a naturally-occurring dipeptide found in muscle and brain. Only the purest ingredients are present in this scientifically-designed formula.

General Statements: All Other Content

9120002 EXP 1211

General Statements: All Other Content

Membrane Stabilizing Anti-Oxidant 50 mg

Manufacturer & Distributor

Distributor

CARDIOVASCULAR RESEARCH, LTD.

CONCORD, CA, 94518

Market Reference

$12.87 – $346.61· 40 listings
  • Carnosine 50 mg

    Covenant Health Products5.0(1)
    $17.95
  • Cardiovascular Research Carnosine 50mg 60 capsules - SPECIAL ORDER

    Wellness Pharmacy5.0(1)
    $17.95
  • Sigma-Aldrich ʟ-Carnosine CAS 305-84-0

    Sigma-Aldrich
    $29.90
  • NOW L-Carnosine 500 mg

    Vitacost.com4.7(1900)
    $36.73
  • L-Carnosine Pure Encapsulations

    Pure Prescriptions4.9(10)
    $87.50
  • Horbäach L-Carnosine 500mg

    Target5.0(4)
    $24.99
  • Life Extension Super Carnosine

    Life Extension4.8(373)
    $30.00
  • Now Foods L Carnosine 500mg 100

    NOW5.0(12)
    $31.99

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease

    E Baye, B Ukropcova, J Ukropec, A Hipkiss, G Aldini… - Amino acids, 2016 - Springer

    … Obesity, type 2 diabetes (T2DM) and cardiovascular disease (CVD) are the most common preventable causes of morbidity and mortality worldwide. They represent major public health …

    201699 citations
  • Effects of carnosine supplementation on glucose metabolism: Pilot clinical trial

    B De Courten, M Jakubova, MPJ De Courten… - …, 2016 - Wiley Online Library

    … and cardiovascular disease, yet there is limited human data. This study investigated whether carnosine … with overweight or obesity improves diabetes and cardiovascular risk factors. …

    2016187 citations
  • Physiological roles of carnosine in myocardial function and health

    JV Creighton, L de Souza Gonçalves… - Advances in …, 2022 - academic.oup.com

    … effect of carnosine on healthy and diseased cardiovascular … This narrative review explores the influence of carnosine and … data from studies concerning both healthy and diseased …

    202262 citations
  • Carnosine did not affect vascular and metabolic outcomes in patients with prediabetes and type 2 diabetes: a 14-week randomized controlled trial

    S Saadati, J Cameron, K Menon, A Hodge, ZX Lu… - Nutrients, 2023 - mdpi.com

    … risk and is a major risk factor for atherosclerotic cardiovascular disease (ASCVD) [2]. … (peripheral vascular disease, ischemic heart disease, coronary artery disease, and stroke) [4]. …

    202315 citations
  • Carnosine and histidine-containing dipeptides improve dyslipidemia: a systematic review and meta-analysis of randomized controlled trials

    K Menon, C Marquina, P Hoj, D Liew, A Mousa… - Nutrition …, 2020 - academic.oup.com

    … Cardiovascular disease is a major public health problem and represents a significant burden of disease … address cardiovascular risk factors to help reduce this growing burden of …

    202016 citations
  • Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo …

    K Menon, JD Cameron, M de Courten, B de Courten - BMJ open, 2021 - bmjopen.bmj.com

    … study is to establish if carnosine supplementation improves obesity, insulin sensitivity, insulin secretion, cardiovascular … cardiovascular disease in the overweight and obese population. …

    202112 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-07-25. DSLD Label ID: 22360. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.